| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |